🇺🇸 Korean red ginseng in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 27

Most-reported reactions

1. Drug Resistance — 5 reports (18.52%)
2. Weight Decreased — 4 reports (14.81%)
3. Herpes Zoster — 3 reports (11.11%)
4. Oral Candidiasis — 3 reports (11.11%)
5. Anaemia — 2 reports (7.41%)
6. Covid-19 — 2 reports (7.41%)
7. Death — 2 reports (7.41%)
8. Diarrhoea — 2 reports (7.41%)
9. Haematoma — 2 reports (7.41%)
10. Product Administration Interrupted — 2 reports (7.41%)

Source database →

Frequently asked questions

Is Korean red ginseng approved in United States?

Korean red ginseng does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Korean red ginseng in United States?

The Korean Society of Ginseng is the originator. The local marketing authorisation holder may differ — check the official source linked above.